Newsroom

MARCH 10 2021 Miriam Tucker The clinical course and prognosis of individuals hospitalized with diabetic ketoacidosis (DKA) are considerably worse among those who have COVID-19, new data show. In-hospital death was sixfold greater among patients with DKA who had COVID-19 compared with those who did not, and acute kidney injury was three times more common. "These findings are worrisome and...

MARCH 8 2021 Through strategic collaboration and the implementation of best practice technology, hospitals can improve care and outcomes for glycemic patients, even amid the pandemic. During Becker's Clinical Leadership and Pharmacy Virtual Forum, experts discussed the importance of strategic collaboration and innovation related to glycemic management during the Feb. 25 featured session...

DECEMBER 2020 Ling Cui, Pamela R. Schroeder and Paul A. Sack Simplified systems were initially developed using this construct to help adjust insulin infusions, but more complex software has since been developed to account for a variety of clinical inpatient scenarios. FDA-approved inpatient electronic glycemic management systems include Glucommander (Glytec), EndoTool System (Monarch Medical...

FEBRUARY 2021 Dawn Antoline-Wang Improved glycemia within the first two or three days of hospitalization is a better predictor of outcomes in COVID-19 patients than glycemia at the time of non-intensive-care-unit (ICU) hospital admission, according to new findings. Glycemia soon after direct ICU admission was not predictive of outcomes in these patients, Dr. David C. Klonoff, medical director...

JANUARY 2021 Kayla Hui, MPH Trying to stay healthy after contracting COVID-19 is one hurdle, but managing it with a chronic disease can be especially challenging. Based on what is known about COVID-19, adults living with an underlying medical condition are at heightened risk for severe illness, especially people living with diabetes.1 As a result, experts are emphasizing people with diabetes...

JANUARY 2021 Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of...

JANUARY 2021 Quinn Phillips For months now, it’s been clear that diabetes is a major risk factor for worse outcomes in people who develop COVID-19. Study after study has shown that people with diabetes are more likely to be hospitalized with the viral illness, and to experience worse outcomes — including a higher risk of death — if they are hospitalized with the disease. But it’s not all doom...

DECEMBER 2020 LabMedica International staff writers Diabetes and hyperglycemia have emerged as important risk factors for hospitalization, disease severity, acute kidney injury, acute respiratory distress syndrome, intensive care unit (ICU) admissions, and death in patients with coronavirus disease 2019 (COVID-19). Hypoglycemia, also called low blood glucose or low blood sugar, occurs when the...

NOVEMBER 2020 Koren Thomas Diabetes nurses work on the frontlines in the fight against an ongoing epidemic/pandemic that will continue to afflict over 13% of the US population long after COVID-19 recedes into the background. The diabetes pandemic has been mounting rapidly in the early 21st century. In 2003, 194 million adults worldwide between the ages of 20 and 79 had diabetes. By 2025, it is...

Collaboration Seeks to Improve Outcomes and Reduce Cost of Care for the 25% of Veterans with Diabetes WALTHAM, MASS. (July 7, 2020) – Glytec, the only provider of insulin management software across the continuum of care, and ThunderCat Technology, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that delivers technology products and services to government organizations, today announced a...